(-0.02%) 5 468.40 points
(-0.04%) 39 097 points
(0.25%) 17 762 points
(-0.63%) $80.32
(-4.32%) $2.64
(-0.88%) $2 310.30
(-0.10%) $28.84
(2.27%) $1 008.80
(0.28%) $0.936
(0.70%) $10.68
(0.47%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States...
Stats | |
---|---|
Today's Volume | 16 500 |
Average Volume | 0 |
Market Cap | 1.14B |
EPS | $-0.170 ( Q3 | 2023-11-06 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0100 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0190 (41.76%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-09 | Casdin Eli | Sell | 755 766 | Earn-out Shares |
2023-11-09 | Casdin Eli | Sell | 5 488 164 | Common Stock |
2023-11-09 | Casdin Eli | Sell | 8 110 001 | Warrants to purchase Class A Common Stock (right to buy) |
2023-11-09 | Casdin Eli | Sell | 101 010 | Stock Option (Right to Buy) |
2023-11-09 | Nallicheri Melanie | Buy | 626 999 | Common Stock |
INSIDER POWER |
---|
-96.90 |
Last 65 transactions |
Buy: 1 747 208 | Sell: 71 082 811 |
Volume Correlation
EQRx, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
EQRx, Inc. Correlation - Currency/Commodity
EQRx, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $0.430 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $0.430 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $0 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
EQRx, Inc.
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. Its product pipeline in development includes Aumolertinib, an EGFR inhibitor for the treatment of ?EGFR-mutated? non-small cell lung cancer (NSCLC); Sugemalimab, an anti-PD-L1 antibody for the treatment of ?stage III and IV ?NSCLC; Lerociclib, a CDK4/6 inhibitor to treat HR+/HER2- breast cancer; and EQ176, an anti-PD-1?antibody for the treatment of liver cancer. The company has partnerships with Exscientia and AbCellera Biologics Inc. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators